(2016). Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973–981. Diabetes Care 39(10), e186-e187.
Owens, D.,Bolli, G.,Charbonnel, B.,Haak, T.,Landgraf, W.,Porcellati, F.,Traylor, L. & Kautzky-Willer, A. (2017). Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ml added to oral antidiabetes agents in type 2 diabetes. Diabetes, Obesity and Metabolism